Literature DB >> 9202551

A case-control study to examine any association between idiopathic detrusor instability and gastrointestinal tract disorder, and between irritable bowel syndrome and urinary tract disorder.

J M Cukier1, M Cortina-Borja, A F Brading.   

Abstract

OBJECTIVE: To assess whether there are common malfunctions (e.g. of the autonomic nervous system and smooth muscle) that underlie disorders of the urinary and gastrointestinal tracts by determining whether there is an increased prevalence (i) of urinary symptoms in patients with irritable bowel syndrome (IBS) and (ii) of gastrointestinal symptoms in patients with idiopathic detrusor instability (IDI). PATIENTS AND METHODS: Questionnaires were sent to patients with a diagnosis of IBS or IDI who were seen in the Departments of Gynaecology, Gastroenterology and Urology at the John Radcliffe and Churchill Hospitals, Oxford, during the 3 year period 1993-1995. The questionnaires were also distributed to control patients who were recruited from the day-surgery unit of the Churchill Hospital. Of 236 questionnaires sent out, 168 replies were analysed; 64 from patients with IBS, 49 from patients with detrusor instability and 55 from controls. The questionnaire included questions about micturition and defecatory behaviour (frequency, regularity, urgency, continence, pain, and ease in passing urine and stools).
RESULTS: Patients with IBS were more likely to experience certain urinary symptoms than controls (nocturia, urgency and some forms of urinary urge incontinence) and patients with IDI were as likely as patients with IBS to experience gastrointestinal symptoms more frequently than controls. Control patients showed an unexpectedly high probability of experiencing many of the gastrointestinal and urinary symptoms.
CONCLUSIONS: The frequent occurrence of symptoms in control patients makes the significance of the results less clear, but the association between certain symptoms of urinary tract disorder and patients with IBS, and of symptoms of gastrointestinal tract disorder with patients with IDI, suggests that they may share some common underlying dysfunction.

Entities:  

Mesh:

Year:  1997        PMID: 9202551     DOI: 10.1046/j.1464-410x.1997.00172.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  11 in total

Review 1.  Combined urinary and faecal incontinence.

Authors:  Dharmesh S Kapoor; Ranee Thakar; Abdul H Sultan
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-02-24

Review 2.  Results of sacral nerve neuromodulation for double incontinence in adults.

Authors:  M Chodez; B Trilling; C Thuillier; B Boillot; S Barbois; J-L Faucheron
Journal:  Tech Coloproctol       Date:  2014-11-08       Impact factor: 3.781

Review 3.  Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review.

Authors:  F A Luscombe
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

4.  Inhibition of NMDAR reduces bladder hypertrophy and improves bladder function in cyclophosphamide induced cystitis.

Authors:  Miao Liu; Shanwei Shen; Derek M Kendig; Sunila Mahavadi; Karnam S Murthy; John R Grider; Li-Ya Qiao
Journal:  J Urol       Date:  2015-01-06       Impact factor: 7.450

Review 5.  Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Chronic linaclotide treatment reduces colitis-induced neuroplasticity and reverses persistent bladder dysfunction.

Authors:  Luke Grundy; Andrea M Harrington; Joel Castro; Sonia Garcia-Caraballo; Annemie Deiteren; Jessica Maddern; Grigori Y Rychkov; Pei Ge; Stefanie Peters; Robert Feil; Paul Miller; Andre Ghetti; Gerhard Hannig; Caroline B Kurtz; Inmaculada Silos-Santiago; Stuart M Brierley
Journal:  JCI Insight       Date:  2018-10-04

7.  Abdominal and Pelvic Pain: Current Challenges and Future Opportunities.

Authors:  Tian Yuan; Beverley Greenwood-Van Meerveld
Journal:  Front Pain Res (Lausanne)       Date:  2021-02-04

8.  NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice.

Authors:  Xiang Xie; Chuang Luo; Jia Yu Liang; Run Huang; Jia Li Yang; Linlong Li; YangYang Li; Hongming Xing; Huan Chen
Journal:  PeerJ       Date:  2021-07-07       Impact factor: 2.984

9.  Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria.

Authors:  Seiji Matsumoto; Kazumi Hashizume; Naoki Wada; Jyunichi Hori; Gaku Tamaki; Masafumi Kita; Tatsuya Iwata; Hidehiro Kakizaki
Journal:  BJU Int       Date:  2012-10-26       Impact factor: 5.588

10.  Changes in mast cell infiltration: a possible mechanism in detrusor overactivity induced by visceral hypersensitivity.

Authors:  Nian-Zhao Zhang; Lin Ma; Chen Jun; Yan-Xia Guo; Hui-Qing Yuan
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.